DRUG · COUNSELLING NOTES
Tildrakizumab
Ilumya
Updated
New prescription
indication: _____. SC wk 0, 4, then q12wk; no live vaccines; warned on allergies; serious/common AEs: URTI, injection-site reaction, serious infection; non-pharm: moisturizers, stress reduction.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; SC wk 0, 4, then q12wk; no live vaccines; warned on allergies; serious/common AEs: URTI, injection-site reaction, serious infection; non-pharm: moisturizers, stress reduction.